Motoko Yamaguchi - Concepedia

Author

Motoko Yamaguchi

Also Known As

Catherine J. Wu, M YAMAGUCHI, M Yamaguchi, M. YAMAGUCHI, M. Yamaguchi, Maho Yamaguchi, Manami Yamaguchi, Mao Yamaguchi, Masahiro Yamaguchi, Masatoshi YAMAGUCHI

349

Publications

7.4K

Citations

H-Index

124

Concepts

All Affiliations

Mie University Aichi Cancer Center Nagoya University Saitama Medical University Tokyo National Hospital

About

Motoko Yamaguchi is an author at Mie University specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	45	2.3K
2	Health Sciences	7	7	448
3	Natural Sciences	2	2	171
4	Allergy	2	2	24
5	Engineering	1	1	27

Motoko Yamaguchi

Publications

6.4K

Citations

H-Index

Page 1

	Year	Citations
Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study Motoko Yamaguchi, Yok‐Lam Kwong, Won Seog Kim, Journal of Clinical Oncology	2011	596
Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5 Takuhei Murase, Motoko Yamaguchi, Ritsuro Suzuki, Blood	2006	438
Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211 Motoko Yamaguchi, Kensei Tobinai, Masahiko Oguchi, Journal of Clinical Oncology	2009	336
De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients Motoko Yamaguchi Blood	2002	317
Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells Motoko Yamaguchi, Kenkichi Kita, Hiroshi Miwa, Cancer	1995	294
Retrospective Analysis of Intravascular Large B-Cell Lymphoma Treated With Rituximab-Containing Chemotherapy As Reported by the IVL Study Group in Japan Kazuyuki Shimada, Kosei Matsue, Kazuhito Yamamoto, Journal of Clinical Oncology	2008	277
Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type Ritsuro Suzuki, Junji Suzumiya, Motoko Yamaguchi, Annals of Oncology Prognostic FactorsLymphoid NeoplasiaMedicineImmunologyPathology	2009	257
Phase I study of dexamethasone, methotrexate, ifosfamide, <scp>l</scp>‐asparaginase, and etoposide (SMILE) chemotherapy for advanced‐stage, relapsed or refractory extranodal natural killer (NK)/T‐cell lymphoma and leukemia Motoko Yamaguchi, Ritsuro Suzuki, Yok‐Lam Kwong, Cancer Science ImmunologyRefractory DiseasesImmunotherapeuticsPharmacotherapyMetronomic Chemotherapy	2008	207
Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma. Yasushi Yatabe, Ritsuro Suzuki, Kensei Tobinai, PubMed	2000	206
Prospective measurement of Epstein-Barr virus–DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type Ritsuro Suzuki, Motoko Yamaguchi, Koji Izutsu, Blood	2011	189

Page 1